针刺治疗腹泻型肠易激综合征:一项先导性随机对照试验的研究方案
本研究为多中心随机对照先导试验,计划纳入90例腹泻型肠易激综合征患者,按1:1:1随机分为特定穴位组、非特定穴位组和非穴位组,评估针刺治疗的有效性与可行性。主要结局为随机化后第4周应答率,即最严重腹痛平均值较基线改善30%且稀便天数较基线减少50%的患者百分比。
要点
- 针刺治疗腹泻型肠易激综合征的证据尚不充分,本试验旨在评估其有效性与可行性
- 90例患者随机分为特定穴位、非特定穴位和非穴位三组,每组30例
- 主要结局为第4周应答率,次要结局包括症状严重程度、抑郁、生活质量等量表
核心结论
- 本研究设计为多中心随机对照先导试验,旨在评估针刺治疗腹泻型肠易激综合征的有效性与可行性。
研究设计与样本
- 多中心随机对照临床试验,计划纳入90例腹泻型肠易激综合征患者。
- 按1:1:1比例随机分为特定穴位组、非特定穴位组和非穴位组。
- 所有患者4周内接受12次针刺治疗,并随访8周。
关键数值与推荐
- 主要结局为随机化后第4周应答率,即最严重腹痛平均值较基线改善30%且稀便天数较基线减少50%的患者百分比。
- 次要结局包括其他时间点应答率、IBS症状严重程度量表(IBS-SSS)、抑郁量表(PHQ-9)、IBS生活质量量表(IBS-QOL)、IBS充分缓解(IBS-AR)、腹痛评分、腹胀评分、布里斯托粪便评分(BBS)、盲法评估和可信度评估。
- 试验期间监测并记录不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal diseases. Although acupuncture has become a common alternative therapy for IBS, there is insufficient evidence for its effectiveness. This study was designed to assess the efficacy and feasibility of acupuncture in the treatment of IBS. METHODS/DESIGN: This is a multicenter randomized controlled clinical trial. According to the ratio of 1:1:1, 90 patients with irritable bowel syndrome will be randomly divided into specific acupoints (SA) group, non-specific acupoints (NSA) group, and non-acupoints (NA) group. All patients will be treated with acupuncture 12 times within 4 weeks and followed up for 8 weeks. The primary outcome is the response rate, the percentage of patients whose average value of worst abdominal pain is 30% better and the days of loose stool is 50% less than the baseline, at week 4 after randomization. The secondary outcomes include the response rates at other time points, IBS Symptom Severity Scale (IBS-SSS), Patient Health Questionnaire-9 depression scale (PHQ-9), IBS-Quality of Life scale (IBS-QOL), IBS Adequate Relief (IBS-AR), Abdominal Pain Score, Abdominal Bloating Score, Bristol Stool Score (BBS), blinding assessment, and credibility evaluation. Adverse events will be monitored and recorded during the trial. TRIAL REGISTRATION: Chictr.org.cn ChiCTR2000030670. Registered on 9 March 2020.
引用
- Qi LY, Wang Y, Wang LQ, et al. Acupuncture for the treatment of diarrheal-predominant irritable bowel syndrome: study protocol for a pilot randomized controlled trial. Trials. 2021. PMID: 33827649. doi:10.1186/s13063-021-05211-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。